What Is Presbyopia and How Is It Treated?
It is a natural fact of life that everybody ages and things that used to be easy become more difficult. This is definitely true for your vision because as you age, you are at higher risk for vision problems and developing common eye diseases.
The word “presbyopia” literally translates to “old eye”, and it is a natural part of the aging process. Presbyopia causes you to lose the ability to see things up close and it often begins to occur after the age of 40. This is why many people need to buy reading glasses as they begin to age.
What is Presbyopia?
When you are young, the lenses in your eyes are soft, flexible, and can change shape easily. Presbyopia happens with the clear lens inside your eye starts to become rigid with age. Because it can’t change shape as easily at it could when you were younger, you have a harder time seeing things up close.
Presbyopia is often confused with farsightedness but they are actually two separate things. Although some of the symptoms are similar, far-sightedness has genetic tendencies and can be present even at birth whereas presbyopia is a natural sign of aging.
If presbyopia is left untreated, it can cause eye strain and discomfort. There is no way to stop or reverse the aging process that causes presbyopia but there are several treatments available. One of those treatments is the Raindrop inlay.
WHAT IS THE RAINDROP NEAR VISION INLAY?
Raindrop is a small transparent disc called an inlay. It’s made of approximately 80% water and from similar material to a soft contact lens. The tiny inlay, about the size of a pinhead, is placed just beneath the surface of your non-dominant eye in a 10-minute outpatient procedure.
The inlay gently changes the shapes of the cornea, the clear front portion of the eye. It is bioengineered to facilitate the transport of nutrients and fluid to the eye. The Raindrop Inlay has a 2mm diameter and is 3 times thinner than a sheet of printer paper.
The Raindrop Near Vision Inlay received U.S. FDA approval in June of 2016 and has been available around the world for several years prior to approval in the U.S.